Selection and topic | Item | Mayo | NIH | Vienna | |||
---|---|---|---|---|---|---|---|
 |  | R1* | R2* | R1* | R2* | R1* | R2* |
TITLE/ABSTRACT | 1. Identify study of diagnostic accuracy | • | • | • | • | • | • |
INTRODUCTION | 2. State the research question | • | • | • | • | • | • |
METHODS | Â | Â | Â | Â | Â | Â | Â |
Participants | 3. Describe study population | • | • | • | • | • | • |
 | 4. Describe participant recruitment | • | • | • | • |  |  |
 | 5. Describe participant sampling | • | • |  | • |  |  |
 | 6. Describe if prospective or retrospective | • | • | • | • |  | • |
Test Methods | 7. Reference standard and rationale | • | • | • | • | • | • |
 | 8. Technical specifications described or referenced | • | • | • | • | • | • |
 | 9. Description of rationale for cut-offs for index tests and reference standards | • | • |  | • | • | • |
 | 10. Description of the number and training of persons executing the tests |  |  |  |  |  |  |
 | 11. Description of blinding of test readers |  |  |  |  |  |  |
Statistical Methods | 12. Description of calculations of diagnostic accuracy and uncertainty | • | • | • | • | • | • |
 | 13. Description of calculations of test reproducibility |  |  |  |  |  | • |
RESULTS | Â | Â | Â | Â | Â | Â | Â |
Participants | 14. Description of duration of study | • | • | • | • |  |  |
 | 15. Description of clinical and demographic description of participants | • | • | • | • | • | • |
 | 16. Description of the number of participants satisfying inclusion criteria that did not undergo the index test or reference standard, and why |  |  | • | • |  |  |
Test Results | 17. Description of the time interval from the index test to the reference standard and any treatment administered between | Â | Â | Â | Â | Â | Â |
 | 18. Description of the severity of disease in those with the target condition; other diagnoses in participants without the target condition | • |  | • |  | • |  |
 | 19. A cross-tabulation of the results of the index tests (including indeterminate and missing tests) | • | • | • | • | • | • |
 | 20. Any adverse events from performing the index or reference tests |  |  |  |  |  |  |
Estimates | 21. Estimates of diagnostic accuracy with statistical uncertainty | • |  | • |  | • |  |
 | 22. Description of how indeterminate results were handled | • | • |  |  |  |  |
 | 23. Estimates of variability between subgroups of patients, readers, or centres | • | • | • | • |  |  |
 | 24. Estimates of test reproducibility |  |  |  |  |  | • |
DISCUSSION | 25. Discussion of the clinical applicability of the findings | • | • | • | • | • | • |